Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease

Abstract

Nitric oxide (^•NO) has been implicated in the immunopathogenesis of MS as a potential mediator of neuronal loss. To investigate the role of .NO in the development of progressive disease we measured the .NO metabolites (nitrate and nitrite) and neopterin, in the urine of 129 patients with demyelinating disease (DD): 23 with clinically isolated syndromes compatible with demyelination and in 46 relapsing remitting (RR) and 60 patients with progressive MS. Eighty-nine of these 129 patients underwent Gd-enhanced MRI. In addition 58 normal control subjects (NC), 19 AIDS and 35 rheumatoid arthritis (RA) patients were studied. Patients with DD, AIDS and RA had significantly elevated urinary nitrate plus nitrite (nit: creat.urine) and neopterin (neopt: creat.urine) to creatinine ratios compared to NC subjects. (Median[25th-75th%] nit: creat.urine: NC=1183_[962-1365] vs DD=1245_[875-2403], AIDS=1686[1231-2531], and RA=1950[1214-2726] mmol/mol, P50.001 and median[25th-75th%] neopt: creat.urine: NC=99_[76-151] vs DD=163_[119-266], AIDS=972_[653-1456], and RA=389_[257-623] mmol/mol, P50.001). Patients with early DD and RR MS had significantly elevated nit: creat.urine compared to patients with progressive MS (nit: creat.urine: 1612[1020-2733] vs 1159_[790-1641] mmol/mol, P=0.006). The nit: creat.urine and neopt: creat.urine did not correlate with clinical relapse or MRI activity. Excretion of .NO metabolites is increased in patients with early or relapsing-remitting disease. .NO appears to be a double-edged sword, mediating tissue damage and modulating complex immunological functions which may be protective in MS.

Keywords

urine nitrate nitrite rheumatoid arthritis HIV-1 HIV-1 infection

Get full access to this article

View all access options for this article.

References

Merril JE , Benveniste EN. (1996) Cytokines in inflamma-tory brain lesions: helpful and harmful . Trends Neurosci 19: 331-338 .

Johnson AW et al. (1995) Evidence for increased nitric oxide production in multiple sclerosis . J Neurol Neurosurg Psychiatry 58: 107-107 .

Giovannoni G. (1998) Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis . Multiple Sclerosis 4: 27-30 .

Giovannoni G et al. (1997) Raised serum nitrate and nitrite levels in patients with multiple sclerosis . JNeurol Sci 145: 77-81 .

deBustos F et al. (1999) Cerebrospinal fluid nitrate levels in patients with multiple sclerosis . Eur Neurol 41: 44-47 .

BöL et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains . Ann Neurol 36: 778-786 .

Bagasara O et al. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis . Proc Natl Acad Sci USA 92: 12041-12045 .

Fuchs D , Weiss G , Reibnegger G , Wachter H. (1992) The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious and malignant diseases . Crit Rev Clin Lab Sci 29: 307-341 .

Zangerle R et al. (1995) Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1 . Immunobiol 193: 59-70 .

10.

Grabowski PS et al. (1996) Elevated nitric-oxide production in rheumatoid arthritis-detection using the fasting urinary nitrate/creatinine ratio . Arthritis Rheum 39: 643-647 .

11.

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 13: 227-231 .

12.

Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

13.

Lublin FD , Reingold SC. (1996) Defining the clinical course of multiple sclerosis: results of an international survey . Neurology 46: 907-911 .

14.

Miller DH et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis . Ann Neurol 39: 6-16 .

15.

Arnett FC et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis . Arthritis Rheum 31: 315-324 .

16.

Felson DT et al. (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials . Arthritis Rheum 36: 729-740 .

17.

Giovannoni G , Land JM , Keir G , Thompson EJ , Heales SJR. (1997). Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels . Ann Clin Biochem 34: 193-198 .

18.

Niederweiser A , Staudenmann W , Wetzel E. (1982) Automatic HPLC of pterins with or without column switching. In: Wachter H , Curtius HC , Pfleider W (eds). Biochemical and Clinical aspects of pteridines.vol1. Berlin: Walter de Gruyter , pp 81-102.

19.

Werner ER et al. (1990) Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T24 cells . J Biol Chem 265: 3189-3192 .

20.

Kwon NY , Nathan CF , Stuehr DJ. (1989) Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages . J Biol Chem 264: 20496-20501 .

21.

Beckman JS et al. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide . Proc Natl Acad Sci USA 87: 1620-1624 .

22.

Langrehr JM , Hoffman RA , Lancaster JR , Simmons RL. (1993) Nitric oxide-a new endogenous immunomodulator . Transplantation 55: 1205-1212 .

23.

Egberts J , Soederhuizen W. (1996) Urine samples before dinner are preferable when studying changes in endogenous nitrate production under uncontrolled dietary conditions . Clin Chim Acta 254: 141-148 .

24.

Giovannoni G et al. (1997) Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis . Brain 120: 1-13 .

25.

Giovannoni G et al. (1997) Raised serum nitrate and nitrite concentrations in patients with multiple sclerosis correlate with lower clinical and MRI levels of disease activity . J Neuroimmunol 80: 182-182 .

26.

Lin RF , Lin TS , Tilton RG , Cross AH. (1993) Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study . J Exp Med 178: 643-648 .

27.

Okuda Y et al. (1995) Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis . JNeuroimmunol 62: 103-112 .

28.

Van Dam AM et al. (1995) Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin . J Neurosci Res 40: 251-260 .

29.

Cross AH et al. (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice . JClin Invest 93: 2684-2690 .

30.

Zielasek J et al. (1995) Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis . J Neuroimmunol 58: 81-88 .

31.

Ruuls SR et al. (1996) Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors . Clin Exp Immunol 103: 467-474 .

32.

Fenyk-Melody JE et al. (1998) Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene . J Immunol 160: 2940-2946 .

33.

Kolb H , et al. (1998) Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 19: 556-561 .

34.

Morrissey SP et al. (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis . Brain 116: 135-146 .

35.

Groeneveld PHP et al. (1996) Increased production of nitric-oxide correlates with viral load and activation of mononuclear phagocytes in HIV-infected patients . Scand J Inf Dis 28: 341-345 .

36.

Reibnegger G et al. (1986) Urinary neopterin reflects clinical disease activity in patients with rheumatoid arthritis . Arthritis Rheum 29: 1063-1070 .

37.

Merril JE , Benveniste EN. (1996) Cytokines in inflamma-tory brain lesions: helpful and harmful . Trends Neurosci 9: 331-338 .